Clinical assessment of memory impairment
42 results
1 - 42
Clinical assessment of memory impairment - Memory complaints, mild cognitive impairment and dementia
- Psychosis in the elderly
Pharmacotherapy for chronic cognitive impairment in traumatic brain injury: Cochrane systematic review
Cognitively enhanced tai chi improves cognition in adults with mild cognitive impairment- Pharmacological treatment for memory disorder in multiple sclerosis: Cochrane systematic review
- Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting
- Vascular cognitive impairment (VCI)
- Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment
- Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment
- Occupational therapy for cognitive impairment in stroke patients
- Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias
- Diagnostic test accuracy of self‐administered cognitive assessment tools for dementia
- Choosing the place of care for an elderly patient with a long-term illness
- Clinical judgement by primary care physicians for the diagnosis of all‐cause dementia or cognitive impairment in symptomatic people
- Mini‐Cog for the detection of dementia within a community setting
- Frontotemporal lobar degeneration
- Montreal Cognitive Assessment for the detection of dementia
- 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- 18F‐FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
- 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- 18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
- CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
- Rivastigmine for vascular cognitive impairment
- Mini‐Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)
- Selegiline for Alzheimer's disease: Cochrane systematic review
- Cholinesterase inhibitors for rarer dementias associated with neurological conditions: Cochrane systematic review
- Addenbrooke’s Cognitive Examination III (ACE‐III) and mini‐ACE for the detection of dementia and mild cognitive impairment
- Electroconvulsive therapy for schizophrenia: Cochrane systematic review
- AD‐8 for detection of dementia across a variety of healthcare settings
- Acetyl‐l‐carnitine for dementia
- Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife
- Metal protein attenuating compounds for the treatment of Alzheimer's dementia: Cochrane systematic review